Current Colorectal Cancer Reports

, Volume 3, Issue 4, pp 191–198 | Cite as

Germline missense mutations in mismatch-repair genes and genetic testing for HNPCC

Article
First Online:
  • 49 Downloads

Abstract

The clinical management of individuals in families with germline mutations in mismatch repair (MMR) genes relies not only on the accurate identification of genetic alterations but also on the interpretation of their pathogenicity. The spectrum of genetic alterations in MMR genes that predispose to hereditary nonpolyposis colorectal cancer (HNPCC) is very diverse. Of all mutations, it is the most difficult to predict the effect of missense mutations on the function of the protein. Therefore it is not always clear whether a missense mutation is pathogenic or just a harmless polymorphism. A number of computational and experimental assays (in vivo and in vitro) have been developed to assess the functional significance of missense mutations in MMR genes. Despite the profusion of such assays, it is not clear that they are sufficiently sensitive and specific to serve as clinically applicable diagnostic tests for HNPCC.

Keywords

Missense Mutation Lynch Syndrome Hereditary Nonpolyposis Colorectal Cancer LoVo Cell Exonic Splice Enhancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Lynch HT, de la Chapelle A: Hereditary colorectal cancer. N Engl J Med 2003, 348:919–932.PubMedCrossRefGoogle Scholar
  2. 2.
    International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer (ICG-HNPCC): Mutation database. Available at www.insight-group.org. Accessed August 21, 2007.Google Scholar
  3. 3.
    Eng C, Vijg J: Genetic testing: the problems and the promise. Nat Biotech 1997, 15:422–426.CrossRefGoogle Scholar
  4. 4.
    van Ommen GJ, Bakker E, den Dunnen JT: The human genome project and the future of diagnostics, treatment, and prevention. Lancet 1999, 354(Suppl 1):SI5–SI10.PubMedGoogle Scholar
  5. 5.
    Hampel H, Frankel WL, Martin E, et al.: Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005, 352:1851–1860.PubMedCrossRefGoogle Scholar
  6. 6.
    Lagerstedt Robinson K, Liu T, Vandrovcova J, et al.: Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst 2007, 99:291–299.PubMedCrossRefGoogle Scholar
  7. 7.
    Papadopoulos N, Leach FS, Kinzler KW, Vogelstein B: Monoallelic mutation analysis (MAMA) for identifying germline mutations. Nat Genet 1995, 11:99–102.PubMedCrossRefGoogle Scholar
  8. 8.
    Yan H, Papadopoulos N, Marra G, et al.: Conversion of diploidy to haploidy. Nature 2000, 403:723–724.PubMedCrossRefGoogle Scholar
  9. 9.
    Casey G, Lindor NM, Papadopoulos N, et al.: Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. JAMA 2005, 293:799–809.PubMedCrossRefGoogle Scholar
  10. 10.
    Cartegni L, Wang J, Zhu Z, et al.: ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 2003, 31:3568–3571.PubMedCrossRefGoogle Scholar
  11. 11.
    Fairbrother WG, Yeh RF, Sharp PA, Burge CB: Predictive identification of exonic splicing enhancers in human genes. Science 2002, 297:1007–1013.PubMedCrossRefGoogle Scholar
  12. 12.
    Zhang XH, Chasin LA: Computational definition of sequence motifs governing constitutive exon splicing. Genes Dev 2004, 18:1241–1250.PubMedCrossRefGoogle Scholar
  13. 13.
    Lastella P, Surdo N, Resta N, et al.: In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon-and tissue-specific effects. BMC Genomics 2006, 7:243.PubMedCrossRefGoogle Scholar
  14. 14.
    Sharp A, Pichert G, Lucassen A, Eccles D: RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1. Hum Mutat 2004, 24:272.PubMedCrossRefGoogle Scholar
  15. 15.
    Auclair J, Buisine MP, Navarro C, et al.: Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing. Hum Mutat 2006, 27:145–154.PubMedCrossRefGoogle Scholar
  16. 16.
    Pagenstecher C, Wehner M, Friedl W, et al.: Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants. Hum Genet 2006, 119:9–22.PubMedCrossRefGoogle Scholar
  17. 17.
    Nakagawa H, Yan H, Lockman J, et al.: Allele separation facilitates interpretation of potential splicing alterations and genomic rearrangements. Cancer Res 2002, 62:4579–4582.PubMedGoogle Scholar
  18. 18.
    Papadopoulos N: Accurate genetic testing platform based on haploid templates: use in inheritable colon cancer. Discov Med 2005, 5:180–185.Google Scholar
  19. 19.
    Pang Q, Prolla TA, Liskay RM: Functional domains of the Saccharomyces cerevisiae Mlh1p and Pms1p DNA mismatch repair proteins and their relevance to human hereditary nonpolyposis colorectal cancer-associated mutations. Mol Cell Biol 1997, 17:4465–4473.PubMedGoogle Scholar
  20. 20.
    Drotschmann K, Clark AB, Kunkel TA: Mutator phenotypes of common polymorphisms and missense mutations in MSH2. Curr Biol 1999, 9:907–910.PubMedCrossRefGoogle Scholar
  21. 21.
    Shimodaira H, Filosi N, Shibata H, et al.: Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae. Nat Genet 1998, 19:384–389.PubMedCrossRefGoogle Scholar
  22. 22.
    Shcherbakova PV, Kunkel TA: Mutator phenotypes conferred by MLH1 overexpression and by heterozygosity for mlh1 mutations. Mol Cell Biol 1999, 19:3177–3183.PubMedGoogle Scholar
  23. 23.
    Ellison AR, Lofing J, Bitter GA: Functional analysis of human MLH1 and MSH2 missense variants and hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae. Hum Mol Genet 2001, 10:1889–1900.PubMedCrossRefGoogle Scholar
  24. 24.
    Kondo E, Suzuki H, Horii A, Fukushige S: A yeast two-hybrid assay provides a simple way to evaluate the vast majority of hMLH1 germ-line mutations. Cancer Res 2003, 63:3302–3308.PubMedGoogle Scholar
  25. 25.
    Guerrette S, Acharya S, Fishel R: The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer. J Biol Chemistry 1999, 274:6336–6341.CrossRefGoogle Scholar
  26. 26.
    Nystrom-Lahti M, Perrera C, Raschle M, et al.: Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer. Genes Chromosomes Cancer 2002, 33:160–167.PubMedCrossRefGoogle Scholar
  27. 27.
    Trojan J, Zeuzem S, Randolph A, et al.: Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. Gastroenterology 2002, 122:211–219.PubMedCrossRefGoogle Scholar
  28. 28.
    Blasi MF, Ventura I, Aquilina G, et al.: A human cell-based assay to evaluate the effects of alterations in the MLH1 mismatch repair gene. Cancer Res 2006, 66:9036–9044.PubMedCrossRefGoogle Scholar
  29. 29.
    Brieger A, Trojan J, Raedle J, et al.: Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants. Gut 2002, 51:677–684.PubMedCrossRefGoogle Scholar
  30. 30.
    Ng PC, Henikoff S: SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 2003, 31:3812–3814.PubMedCrossRefGoogle Scholar
  31. 31.
    Ramensky V, Bork P, Sunyaev S: Human non-synonymous SNPs: server and survey. Nucleic Acid Res 2002, 30:3894–3900.PubMedCrossRefGoogle Scholar
  32. 32.
    Ollila S, Sarantaus L, Kariola R, et al.: Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein. Gastroenterology 2006, 131:1408–1417.PubMedCrossRefGoogle Scholar
  33. 33.
    Belvederesi L, Bianchi F, Loretelli C, et al.: Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features. Eur J Hum Genet 2006, 14:853–859.PubMedCrossRefGoogle Scholar
  34. 34.
    Kariola R, Raevaara TE, Lonnqvist KE, Nystrom-Lahti M: Functional analysis of MSH6 mutations linked to kindreds with putative hereditary non-polyposis colorectal cancer syndrome. Hum Mol Genet 2002, 11:1303–1310.PubMedCrossRefGoogle Scholar
  35. 35.
    Ollila S, Fitzpatrick R, Sarantaus L, et al.: The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC. Int J Oncol 2006, 28:149–153.PubMedGoogle Scholar
  36. 36.
    Raevaara TE, Korhonen MK, Lohi H, et al.: Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1. Gastroenterology 2005, 129:537–549.PubMedGoogle Scholar
  37. 37.
    Takahashi M, Shimodaira H, Andreutti-Zaugg C, et al.: Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays. Cancer Res 2007, 67:4595–4604.PubMedCrossRefGoogle Scholar
  38. 38.
    Lucci-Cordisco E, Boccuto L, Neri G, Genuardi M: The use of microsatellite instability, immunohistochemistry and other variables in determining the clinical significance of MLH1 and MSH2 unclassified variants in Lynch syndrome [review]. Cancer Biomark 2006, 2:11–27.PubMedGoogle Scholar
  39. 39.
    Mangold E, Pagenstecher C, Friedl W, et al.: Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining. J Pathol 2005, 207:385–395.PubMedCrossRefGoogle Scholar
  40. 40.
    Scherer SJ, Avdievich E, Edelmann W: Functional consequences of DNA mismatch repair missense mutations in murine models and their impact on cancer predisposition. Biochem Soc Trans 2005, 33:689–693.PubMedCrossRefGoogle Scholar
  41. 41.
    Marra G, D’Atri S, Yan H, et al.: Phenotypic analysis of hMSH2 mutations in mouse cells carrying human chromosomes. Cancer Res 2001, 61:7719–7721.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Sidney Kimmel Comprehensive Cancer CenterThe Johns Hopkins InstitutionsBaltimoreUSA

Personalised recommendations